U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35 books (113 items)

1.
Endotext [Internet].

Endotext [Internet].

Feingold KR, Adler RA, Ahmed SF, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

2.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

3.
GeneReviews® [Internet].

GeneReviews® [Internet].

Adam MP, Bick S, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2026.

4.
IRIS Toxicological Review of Hexavalent Chromium [Cr(VI)] CASRN 18540-29-9.

IRIS Toxicological Review of Hexavalent Chromium [Cr(VI)] CASRN 18540-29-9.

Gibbons CF, Sasso AF, Angrish MM, et al.

Washington (DC): U.S. Environmental Protection Agency; 2024 Aug.

5.
Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures.

Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2010. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 92.)

6.
Drinking Coffee, Mate, and Very Hot Beverages.

Drinking Coffee, Mate, and Very Hot Beverages.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2018. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 116.)

7.
Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study.

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study.

Whitaker LHR, Middleton LJ, Priest L, et al.

Southampton (UK): National Institute for Health and Care Research; 2023 Oct. (Efficacy and Mechanism Evaluation, No. 10.08.)

9.
IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA) and Related Salts CASRN 335-76-2.

IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA) and Related Salts CASRN 335-76-2.

Kaiser JP, Lizarraga L, Arzuaga X, et al.

Washington (DC): U.S. Environmental Protection Agency; 2024 Jul.

10.
Sex and Gender Identification and Implications for Disability Evaluation.

Sex and Gender Identification and Implications for Disability Evaluation.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Sex and Gender Identification and Implications for Disability Evaluation; Malcarney MB, Amaro HdlA, editors.

Washington (DC): National Academies Press (US); 2024 Nov 18.

11.
Toxicological Profile for Tin and Tin Compounds.

Toxicological Profile for Tin and Tin Compounds.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2005 Aug.

12.
Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health.

Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division on Earth and Life Studies; Board on Health Sciences Policy; Board on Environmental Studies and Toxicology; Ocean Studies Board; Committee on Environmental Impact of Currently Marketed Sunscreens and Potential Human Impacts of Changes in Sunscreen Usage.

Washington (DC): National Academies Press (US); 2022 Aug 9.

13.
Skills in Rheumatology [Internet].

Skills in Rheumatology [Internet].

Almoallim H, Cheikh M, editors.

Singapore: Springer; 2021.

14.
The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use.

The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Replacement Therapy; Jackson LM, Parker RM, Mattison DR, editors.

Washington (DC): National Academies Press (US); 2020 Jul 1.

15.
Hormonal Contraception and Post-menopausal Hormonal Therapy.

Hormonal Contraception and Post-menopausal Hormonal Therapy.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 72.)

16.
Bitumens and Bitumen Emissions, and Some N- and S-Heterocyclic Polycyclic Aromatic Hydrocarbons.

Bitumens and Bitumen Emissions, and Some N- and S-Heterocyclic Polycyclic Aromatic Hydrocarbons.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): World Health Organization; 2013.

17.
Dietary Supplements: A Framework for Evaluating Safety.

Dietary Supplements: A Framework for Evaluating Safety.

Institute of Medicine (US) and National Research Council (US) Committee on the Framework for Evaluating the Safety of Dietary Supplements.

Washington (DC): National Academies Press (US); 2005.

18.
Neurobiology of Body Fluid Homeostasis: Transduction and Integration.

Neurobiology of Body Fluid Homeostasis: Transduction and Integration.

De Luca LA Jr, Menani JV, Johnson AK, editors.

Boca Raton (FL): CRC Press/Taylor & Francis; 2014.

20.
Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS).

Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS).

IARC Working Group on the Identification of Carcinogenic Hazards to Humans.

Lyon (FR): International Agency for Research on Cancer; 2025. (IARC Monographs on the Identification of Carcinogenic Hazards to Humans, No. 135.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...